Vivimed Labs (NSE:VIVIMEDLAB) E10: ₹-1.85 (As of Dec. 2025)


NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
33 GF Score
Price ₹5.71
GF Value ₹2.57
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs E10?

Vivimed Labs NSE:VIVIMEDLAB -0.87% 33 E10 is ₹-1.85 as of Dec. 2025. GuruFocus rates NSE:VIVIMEDLAB with a GF Score™ of 33/100 and a GF Value™ of ₹2.57 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vivimed Labs's adjusted earnings per share data for the three months ended in Dec. 2025 was ₹-2.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-1.85 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Vivimed Labs's average E10 Growth Rate was -660.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Vivimed Labs was -44.40% per year. The lowest was -44.40% per year. And the median was -44.40% per year.

As of today (2026-06-26), Vivimed Labs's current stock price is ₹5.71. Vivimed Labs's E10 for the quarter that ended in Dec. 2025 was ₹-1.85. Vivimed Labs's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Vivimed Labs was 14.85. The lowest was 1.04. And the median was 2.02.


Vivimed Labs  (NSE:VIVIMEDLAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Vivimed Labs was 14.85. The lowest was 1.04. And the median was 2.02.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vivimed Labs E10 Related Terms


Vivimed Labs E10 Historical Data

* Premium members only.

The historical data trend for Vivimed Labs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivimed Labs E10 Chart

Vivimed Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.03 8.82 3.47 1.72 -0.10

Vivimed Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 -0.10 -0.65 -1.22 -1.85

NSE:VIVIMEDLAB vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivimed Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivimed Labs Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivimed Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vivimed Labs's Shiller PE Ratio falls into.


NSE:VIVIMEDLAB
33GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vivimed Labs's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-2/163.2808*163.2808
=-2.000

Current CPI (Dec. 2025) = 163.2808.

Vivimed Labs Quarterly Data

per share eps CPI Adj_EPS
201603 7.550 102.518 12.025
201606 3.310 105.961 5.101
201609 3.220 105.961 4.962
201612 6.190 105.196 9.608
201703 12.810 105.196 19.883
201706 2.860 107.109 4.360
201709 2.692 109.021 4.032
201712 2.500 109.404 3.731
201803 1.070 109.786 1.591
201806 3.310 111.317 4.855
201809 2.120 115.142 3.006
201812 1.260 115.142 1.787
201903 -0.030 118.202 -0.041
201906 1.190 120.880 1.607
201909 -3.180 123.175 -4.215
201912 -3.870 126.235 -5.006
202003 -7.340 124.705 -9.611
202006 1.500 127.000 1.929
202009 -1.640 130.118 -2.058
202012 -5.980 130.889 -7.460
202103 -3.310 131.771 -4.102
202106 -0.280 134.084 -0.341
202109 -2.810 135.847 -3.377
202112 -0.290 138.161 -0.343
202203 -2.211 138.822 -2.601
202206 -2.680 142.347 -3.074
202209 -2.660 144.661 -3.002
202212 -2.210 145.763 -2.476
202303 -32.080 146.865 -35.666
202306 -1.880 150.280 -2.043
202309 -2.450 151.492 -2.641
202312 -1.940 152.924 -2.071
202403 0.640 153.035 0.683
202406 -1.840 155.789 -1.928
202409 -0.620 157.882 -0.641
202412 -0.720 158.323 -0.743
202503 -0.670 157.552 -0.694
202506 -0.660 159.755 -0.675
202509 -0.880 162.289 -0.885
202512 -2.000 163.281 -2.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹-1.85 mean?
Vivimed Labs (NSE:VIVIMEDLAB) has a E10 of ₹-1.85 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vivimed Labs and its competitors.
Is Vivimed Labs' E10 too high?
Vivimed Labs' current E10 is ₹-1.85. Overall, Vivimed Labs has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vivimed Labs' E10 compare to ZTS?
Vivimed Labs' E10 of ₹-1.85 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vivimed Labs and its competitors. Vivimed Labs's current E10 is ₹-1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivimed Labs stock overvalued right now?
Based on GuruFocus' analysis, Vivimed Labs (NSE:VIVIMEDLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.57, compared to a current price of ₹5.71 — trading 122.2% above its estimated fair value. The current E10 is ₹-1.85. Vivimed Labs' overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Vivimed Labs (NSE:VIVIMEDLAB), the current E10 is ₹-1.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.71 is trading 122.2% above its estimated GF Value™ of ₹2.57. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • E10: ₹-1.85
  • GF Value™: ₹2.57 vs. price of ₹5.71 (122.2% above fair value)
  • GF Score™: 33/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
33GF Score

Get the complete analysis for NSE:VIVIMEDLAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.71
Price
₹2.57
GF Value